Investigation Overview
June 7, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Transgenomic Inc (NASDAQ:TBIO) was announced over potential breaches of fiduciary duties by certain officers and directors at Transgenomic. The investigation by a law firm concerns whether certain Transgenomic officers and directors breached their fiduciary duties and cause...
You must register (for free) or login to view the entire investigation.